Abstract
Purpose
Simultaneous analyses of the contents and ratios of 12 cytokines and growth factors in single samples of human tears were performed, and the results were compared between a group of healthy subjects and a group of patients with Graves’ hyperthyreosis (GH) without thyroid-associated orbitopathy (TAO).
Methods
Determinations and concentration measurements of interleukins (IL-2, IL4, IL-6, IL-8, IL-10, IL-1α, and IL-1β) interferon (IFN-γ), tumor necrosis factor (TNF-α), monocyte chemoattractant protein (MCP-1), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF) were performed with single tear samples from 21 patients with hyperthyreosis and 22 healthy subjects. The analyses were performed using a Randox microchip with an Evidence Biochip Array Analyzer.
Results
We found significant differences between the healthy donor group and the hyperthyreosis group in the levels of IL-6, IL-10, VEGF, IL-1α, and MCP-1. The concentration of IL-6 was considerably higher in the hyperthyreosis group, IL-10 was higher in the healthy donor group, and VEGF and MPC-1 were higher in the hyperthyreosis group. The IL-8 and IFN-γ levels were higher in the hyperthyreosis group. The ratios of all of the cytokines to anti-inflammatory IL-10 were significantly elevated in the hyperthyreosis group.
Conclusion
There are clear differences in the levels of cytokines and growth factors in the tears of healthy subjects and patients with GH without TAO. Tear cytokine changes and related dysfunctional tear syndrome (DTS) could be an early sign of occult TAO in Graves’ hyperthyreosis patients.
Similar content being viewed by others
References
Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP (2001) Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 254:109–118
Baudouin C (2007) A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol 30:239–246
Kenyon NJ, Kelly EA, Jarjour NN (2000) Enhanced cytokine generation by peripheral blood mononuclear cells in allergic and asthma subjects. Ann Allergy Asthma Immunol 85:115–120
Gilbard JP, Farris RL (1983) Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol 61:108–116
Iskeleli G, Karakoc Y, Abdula A (2008) A tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol 52:323–326. https://doi.org/10.1007/s10384-008-0545-7
Khurana AK, Sunder S, Ahluwalia BK, Malhotra KC (1992) Tear film profile in Graves’ ophthalmopathy. Acta Ophthalmol 70:346–349
Villani E, Viola F, Sala R, Salvi M, Mapelli C, Currò N, Vannucchi G, Beck-Peccoz P, Ratiglia R (2010) Corneal involvement in Graves’ orbitopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci 51:4574–4578. https://doi.org/10.1167/iovs.10-5380
Khalil HA, Dekeizer RJ, Kijlstra A (1988) Analysis of tear proteins in Graves’ ophthalmopathy by high-performance liquid-chromatography. Am J Ophthalmol 106:186–190
Zoukhri D (2006) Effect of inflammation on lacrimal gland function. Exp Eye Res 82:885–898. https://doi.org/10.1016/j.exer.2005.10.018
Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Hamrah P, Jurkunas U, Schaumberg DA, Dana R (2013) Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. JAMA Ophthalmol 131:715–723. https://doi.org/10.1001/jamaophthalmol.2013.195
Sonawane S, Khanolkar V, Namavari A, Chaudhary S, Gandhi S, Tibrewal S, Jassim SH, Shaheen B, Hallak J, Horner JH, Newcomb M, Sarkar J, Jain S (2012) Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease. Invest Ophthalmol Vis Sci 53:8253–8282. https://doi.org/10.1167/iovs.12-10430
Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Köhler K, Esser J, Krüger C, Quadbeck B, Steuhl KP, Gieseler RK (2004) Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand 82:291–297
Gupta A, Sadeghi PB, Akpek EK (2009) Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol 147:919–923. https://doi.org/10.1016/j.ajo.2008.12.007
Huang D, Xu N, Song Y, Wang P, Yang H (2012) Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 250:619–625. https://doi.org/10.1007/s00417-011-1863-x
Huang D, Quan L, Huasheng Y, Yuxiang M (2014) Changes of lacrimal gland and tear inflammatory cytokines in thyroid associated orbitopathy. IOVS 55:4935–4943. https://doi.org/10.1167/iovs.13-13704
Chang TC, Huang KM, Chang TJ, Lin SL (1990) Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves’ disease. Clin Endocrinol 32:551–558
Ludgate M, Baker G (2002) Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2:193–198. https://doi.org/10.1046/j.1365-2249.2002.01792.x
Dias AC, Modulo CM, Jorge AG, Braz AM, Jordao AA, Bertazolli R, de Paula JS, Rocha EM (2007) Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest Ophthalmol Vis Sci 48:3038–3042
Ujhelyi B, Gogolak P, Erdei AM, Nagy V, Balasz E, Rajnavolgyi E, Berta A, Nagy EV (2012) Graves’ orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid 22:407–414. https://doi.org/10.1089/thy.2011.0248
Mourits MP (1990) Current concepts on Graves’ ophthalmopathy. In: Mourits MP (ed) Management of Graves’ ophthalmopathy. Rodopi, Amsterdam, pp 7–8
Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55:1735–1748. https://doi.org/10.1167/iovs.14-14002
Yoon JS, Choi SH, Lee JH, Lee SJ, Lee SY (2010) Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 248:271–276. https://doi.org/10.1007/s00417-009-1215-2
Rajaii F, McCoy AN, Smith TJ (2014) Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: from bench to bedside. Expert Rev Ophthalmol 9:227–234. https://doi.org/10.1586/17469899.2014.917960
Tan X, Sun S, Liu Y, Zhu T, Wang K, Ren T, Wu Z, Xu H, Zhu L (2014) Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome. Eye 28:608–613. https://doi.org/10.1038/eye.2014.38
Barabino S, Chen Y, Chauhan S, Dana R (2012) Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 31:271–285. https://doi.org/10.1016/j.preteyeres.2012.02.003
Mathers WD (2000) Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO J 26:159–165
Dartt DA (2004) Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul Surf 2:76–91
Knop E, Knop N, Brewitt H (2003) Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease. Ophthalmologe 100:917–928
Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Katsikis P, Londei M, Abney E, Buchan G, Barrett K et al (1991) Cytokine assays—role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 119:105–123
Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E (1996) Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves’ disease. J Clin Endocrinol Metab 81:2976–2979
Gorman CA (2005) Pathogenesis of graves’ ophthalmopathy. In: Rootman JJ (ed) Orbital disease: present status and future challenges. Taylor and Francis, New York, pp 147–148
Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC (2009) Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 147:198–205. https://doi.org/10.1016/j.ajo.2008.08.032
Shen J, Li Z, Li W, Ge Y, Xie M, Lv M, Fan Y, Chen Z, Zhao D, Han Y (2015) Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Disease Markers 2015:609593–609598. https://doi.org/10.1155/2015/609593
Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19:495–501. https://doi.org/10.1089/thy.2008.0423
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Mandić, J.J., Kozmar, A., Kusačić-Kuna, S. et al. The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis. Graefes Arch Clin Exp Ophthalmol 256, 845–852 (2018). https://doi.org/10.1007/s00417-017-3892-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3892-6